BlackRock Health Sciences Trust (NYSE: BME) — Perfil da empresa, notícias e dados financeiros
BlackRock Health Sciences Trust invests in healthcare companies aiming for capital appreciation and exposure to health sciences.
BlackRock Health Sciences Trust
BlackRock Health Sciences Trust (NYSE:BME) focuses on capital appreciation by investing in a dynamic portfolio of healthcare and sciences companies. With investments ranging across pharmaceuticals, biotechnology, and healthcare equipment and services, it aims to provide investors with exposure to the growth potential of the health sciences sector. The trust's projects involve actively managing investments in public health sciences companies, with the objective of achieving long-term capital growth. Through its strategic allocations, BlackRock Health Sciences Trust seeks to capitalize on the evolving landscape of the healthcare industry, including technological advancements and demographic shifts affecting health services demand.
Resumo
Operações
Produtos e/ou serviços de BlackRock Health Sciences Trust
- Investment in biotechnology firms focusing on groundbreaking medical and healthcare innovations.
- Portfolio management services that target the health sciences sector, optimizing investment returns.
- Research and development funding for pharmaceutical advancements, enhancing drug discovery processes.
- Equity investments in medical device companies, supporting the creation of cutting-edge healthcare equipment.
- Healthcare sector analysis and financial advising, providing insights for informed investment decisions.
- Educational initiatives and seminars on health sciences investment strategies, empowering investors.
equipe executiva do BlackRock Health Sciences Trust
- Charles Choon Sik ParkChief Compliance Officer and Anti-Money Laundering Officer
- Thomas P. CallanPortfolio Manager
- Kyle G. McClementsPortfolio Manager
- Erin XiePortfolio Manager
- Xiang LiuPortfolio Manager
Histórico de dividendos
Dividendos por ação pagos pela BlackRock Health Sciences Trust, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | $3.1447 |
| FY2025 | — | — | — | $3.1440 |
| FY2024 | — | — | — | $2.6050 |
| FY2023 | — | — | — | $2.5560 |
| FY2022 | — | — | — | $2.5560 |
Principais indicadores financeiros
Resultados divulgados pela BlackRock Health Sciences Trust, em USD.
- Cap. de mercado
- 583 mi
- Receita (TTM)
- 7,6 mi
- P/L
- 5.6
- LPA (diluído, TTM)
- 8.1
- Dividend yield
- 7.0%
- Margem de lucro
- 1371.2%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 36,2 mi | 77 mi | 77 mi | |
| 24,1 mi | 23,5 mi | 23,5 mi | |
| 34,9 mi | 8,5 mi | 20 mi | |
| -26 mi | -26,5 mi | -26,5 mi |